Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review
Qian Chen, Kai Zheng, Ming Xu, Ning Yan, Gong Hai, Xiuchun Yu · 2023
Read Anlotinib combined with radiotherapy and chemotherapy for recurrent pelvic osteosarcoma treatment: a case report and literature review by Qian Chen, Kai Zheng, Ming Xu, Ning Yan, Gong Hai, Xiuchun Yu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10753991.txt.
Description
Qian Chen and five co-authors present a 2023 case report on a rare bone cancer. The patient was a man of twenty nine with pelvic osteosarcoma that had returned. Scans showed a tumor with rich blood flow and strong contrast uptake. Surgery was not an option in his case.
The team treated him with a drug called anlotinib after chemotherapy. During the first chemo course he also got focused radiation at a high total dose. The drug targets blood vessel growth that feeds tumors. Twenty five months after the combined treatment, no return of disease had been found. The authors pair the case with a review of past reports. Single cases cannot prove a treatment works, but they can point to options worth testing.
Catalog record
| CREATOR | Qian Chen, Kai Zheng, Ming Xu, Ning Yan, Gong Hai, Xiuchun Yu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |